Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Real-World Study of Glofitamab for the Treatment of Relapse or Refractory Diffuse Large B-Cell Lymphoma in East China

Jiefeng Tong, Songfu Jiang, Qian Luo, Shanhu Qian, Guifang Ouyang, Yanli Lai, Huifang Jiang, Yuxia Jiang, Hui Zeng, Baodong Ye, Wei Jiang, Wenbin Qian

Blood (2024) 144 (Supplement 1): 7762.

https://doi.org/10.1182/blood-2024-204522

Published: 2024

Journal Articles

Updated Results from a Phase Ⅱ Clinical Trial：Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia

Chuting Yang, Rui Huang, Danian Nie, Yiqing Li, Yuming Zhang, Honghua He, Chaoyang Song, Sanfang Tu, Yaling Zheng, Xuan Zhou, Jie Chen, Hui Zeng, Yuhua Li

Blood (2024) 144 (Supplement 1): 1050.

https://doi.org/10.1182/blood-2024-201586

Published: 2024

Journal Articles

Low-Dose Corticosteroids and Eltrombopag in the Treatment of Newly Diagnosed Adult Immune Thrombocytopenia: A Multicenter, Phase 2 Clinical Trial

Blood (2024) 144 (Supplement 1): 3949.

https://doi.org/10.1182/blood-2024-201872

Published: 2024

Journal Articles

Loss of Cpt1a Results in Elevated Mitochondrial Reactive Oxygen Species from Glucose-Fueled Mitochondrial Oxidative Phosphorylation and Defective Hematopoietic Stem Cells

Jue Li, Michihiro Hashimoto, Mingzhe Pan, Hui Zeng, Paul R. Andreassen, Gang Huang

Blood (2024) 144 (Supplement 1): 4035.

https://doi.org/10.1182/blood-2024-206240

Published: 2024

Journal Articles

A Prospective, Multicenter, Single-Arm Study on the Combination of Orelabrutinib and Rituximab in the Second-Line Treatment of Relapsed/Refractory Marginal Zone Lymphoma

Guifang Ouyang, Lixia Sheng, Jiaping Wang, Hui Zeng, Shanhao Tang, Xibin Xiao, Yamin Tan, Qunyi Guo, Yanping Shao, Minchao Yan, Wenbin Qian

Blood (2024) 144 (Supplement 1): 4391.

https://doi.org/10.1182/blood-2024-198485

Published: 2024

Journal Articles

Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Trial

Chuting Yang, Yaling Zheng, Chaoyang Song, Ming Wu, Lei Wang, Xuan Zhou, Chunyan Yue, Xiaonan Lin, Jie Chen, Hui Zeng, Rui Huang, Yuhua Li

Blood (2023) 142 (Supplement 1): 7045.

https://doi.org/10.1182/blood-2023-174879

Published: 2023

Journal Articles

Venetoclax Combined with HMA Versus CAG Based Chemotherapy in Acute Myeloid Leukemia: A Propensity Score Matched Analysis

Xiaonan Lin, Yuming Zhang, Ying Zhao, Ying Dong, Xiaotao Wang, Pengcheng Huang, Zhenqian Huang, Honghua He, Xiaoli Xu, Yaya Wang, Fang Jiang, Hui Zeng, Rui Huang, Yuhua Li

Blood (2023) 142 (Supplement 1): 2901.

https://doi.org/10.1182/blood-2023-182642

Published: 2023

Journal Articles

Venetoclax Plus Azacitadine for Middle Aged and Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial

Blood (2023) 142 (Supplement 1): 4263.

https://doi.org/10.1182/blood-2023-177568

Published: 2023

Journal Articles

PET Tracer-Based Glucose Uptake Predicts Clinical Response to Induction Therapy in Acute Myeloid Leukaemia

Hui Zeng, Suqi Deng, Juan Du, Huien Zhan, Kexiu Huang, Xue Zheng, Ying Xu, Lu Wang

Blood (2023) 142 (Supplement 1): 1592.

https://doi.org/10.1182/blood-2023-189148

Published: 2023

Journal Articles

ABC Regimen (Azacitidine, Venetoclax and Chidamide) Is Comparable to the “3+7” Regimen in Newly Diagnosed AML: A Real-World Experience from South China

Blood (2023) 142 (Supplement 1): 1522.

https://doi.org/10.1182/blood-2023-188196

Published: 2023

Journal Articles

Gilteritinib-Based Combination Therapy in Adult Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia

Nianci Chen, Jiajia Pan, Yile Zhou, Liping Mao, Yinjun Lou, Jiejing Qian, Gaixiang Xu, Juying Wei, De Zhou, Lihong Shou, Huang Li, Minchao Yan, Hui Zeng, Cuihua Fan, Gongqiang Wu, Weiying Feng, Hongyan Tong, Jie Jin, Huafeng Wang

Blood (2023) 142 (Supplement 1): 5926.

https://doi.org/10.1182/blood-2023-182806

Published: 2023

Journal Articles

Hexamethylene Amiloride Sensitizes AML to Venetoclax through Inducing Lysosomal Membrane Permeabilization

Hui Zeng, Xinya Jiang, Juan Du, Lei Hua, Xiaofan Sun, Fangshu Liu

Blood (2022) 140 (Supplement 1): 8797–8798.

https://doi.org/10.1182/blood-2022-164960

Published: 2022

Journal Articles

Hyperglycemia Induces Endothelial Dysfunction through Hedgehog Signaling-Mediated TNF-α Production

Hui Zeng, Shurong Xie, Heng Wan, Heng Meng, Bo Hu, Juan Du

Blood (2022) 140 (Supplement 1): 2667–2668.

https://doi.org/10.1182/blood-2022-163132

Published: 2022

Journal Articles

Recurrent Venous and Arterial Thrombosis By Prothrombin p.R596Q Heterozygous Mutation in a Chinese Patient: A Case Report and Literature Review

Rong-Fu Zhou, PhD MD, WANG JUN, MD, Xu Peng, MD, Hui Zeng, MD, Yong Xu, PhD, Yueyi Xu, MD, Min Zhou, Peipei Xu, Bing Chen

Blood (2019) 134 (Supplement_1): 4947.

https://doi.org/10.1182/blood-2019-130459

Published: 2019

Journal Articles

Compound Heterozygous Nonsense Mutations Leading to Hereditary Deficiency of Coagulation Factor XI in a Chinese Pedigree

Qian Li, Hui Zeng, Yong Xu, Min Zhou, Bing Chen, Rong-Fu Zhou, PhD MD

Blood (2018) 132 (Supplement 1): 5032.

https://doi.org/10.1182/blood-2018-99-118105

Published: 2018

Journal Articles

Successful Management of a Left-Sided Endocarditis Patient Complicated with Hemophagocytic Lymphohistiocytosis---a Rare Case Report and Literature Review

Qiguo Zhang, MD, Hui Zeng, MD, Peipei Xu, MD, Jing Wang, MD, Ronggong Yang, MD, Jingyan Xu, MD, Rongfu Zhou, MD, Jian Ouyan, MD, Bing Chen, MD

Blood (2016) 128 (22): 4889.

https://doi.org/10.1182/blood.V128.22.4889.4889

Published: 2016

Journal Articles

The Clinical Significance of Argonaute 2 Expression and Angiogenesis in Multiple Myeloma

Qiguo Zhang, MD, Hongyan Wu, Jian Ouyang, MD, Bing Chen, MD, Haibo Dong, MD, Rong-Fu Zhou, MD, Hui Zeng, MD, Min Zhou, MD

Blood (2015) 126 (23): 5312.

https://doi.org/10.1182/blood.V126.23.5312.5312

Published: 2015

Journal Articles

Defects in Early Lymphopoiesis Contribute to Sepsis-Induced Thymic Atrophy

Yaxian Kong, PhD, Weimei Zhang, Yajie Li, Hong Zheng, MD PhD, Christian Kosan, PhD, Hui Zeng, MD PhD

Blood (2014) 124 (21): 4328.

https://doi.org/10.1182/blood.V124.21.4328.4328

Published: 2014

Journal Articles

PTEN Regulated BCRP/ABCG2 and Side Population Through PI3K/Akt Pathway In Chronic Myeloid Leukemia

Fang-Fang Huang, Li Zhang, Yan-Hui Yu, Fang-ping Chen, M.D., Hui Zeng, Ting Niu, MD, PhD, Deng-shu Wu

Blood (2013) 122 (21): 5408.

https://doi.org/10.1182/blood.V122.21.5408.5408

Published: 2013

Journal Articles

TLR-Signaling Induces Granulocytic MDSCs Generation by Directing Myeloid Lineage Commitment During Polymicrobial Sepsis

Yaxian Kong, Weimei Zhang, Wei Liu, Peng Miao, Hui Zeng

Blood (2011) 118 (21): 2160.

https://doi.org/10.1182/blood.V118.21.2160.2160

Published: 2011

NARROW

Real-World Study of Glofitamab for the Treatment of Relapse or Refractory Diffuse Large B-Cell Lymphoma in East China

Updated Results from a Phase Ⅱ Clinical Trial：Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia

Low-Dose Corticosteroids and Eltrombopag in the Treatment of Newly Diagnosed Adult Immune Thrombocytopenia: A Multicenter, Phase 2 Clinical Trial

Loss of Cpt1a Results in Elevated Mitochondrial Reactive Oxygen Species from Glucose-Fueled Mitochondrial Oxidative Phosphorylation and Defective Hematopoietic Stem Cells

A Prospective, Multicenter, Single-Arm Study on the Combination of Orelabrutinib and Rituximab in the Second-Line Treatment of Relapsed/Refractory Marginal Zone Lymphoma

Safety and Efficacy of Azacitidine and Chidamide Maintenance after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with High-Risk Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Trial

Venetoclax Combined with HMA Versus CAG Based Chemotherapy in Acute Myeloid Leukemia: A Propensity Score Matched Analysis

Venetoclax Plus Azacitadine for Middle Aged and Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: Interim Analysis of a Prospective, Multicenter, Single-Arm, Phase 2 Trial

PET Tracer-Based Glucose Uptake Predicts Clinical Response to Induction Therapy in Acute Myeloid Leukaemia

ABC Regimen (Azacitidine, Venetoclax and Chidamide) Is Comparable to the “3+7” Regimen in Newly Diagnosed AML: A Real-World Experience from South China

Gilteritinib-Based Combination Therapy in Adult Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia

Hexamethylene Amiloride Sensitizes AML to Venetoclax through Inducing Lysosomal Membrane Permeabilization

Hyperglycemia Induces Endothelial Dysfunction through Hedgehog Signaling-Mediated TNF-α Production

Recurrent Venous and Arterial Thrombosis By Prothrombin p.R596Q Heterozygous Mutation in a Chinese Patient: A Case Report and Literature Review

Compound Heterozygous Nonsense Mutations Leading to Hereditary Deficiency of Coagulation Factor XI in a Chinese Pedigree

Successful Management of a Left-Sided Endocarditis Patient Complicated with Hemophagocytic Lymphohistiocytosis---a Rare Case Report and Literature Review

The Clinical Significance of Argonaute 2 Expression and Angiogenesis in Multiple Myeloma

Defects in Early Lymphopoiesis Contribute to Sepsis-Induced Thymic Atrophy

PTEN Regulated BCRP/ABCG2 and Side Population Through PI3K/Akt Pathway In Chronic Myeloid Leukemia

TLR-Signaling Induces Granulocytic MDSCs Generation by Directing Myeloid Lineage Commitment During Polymicrobial Sepsis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only